Principal Financial Group’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-12,860
| Closed | -$288K | – | 2351 |
|
|
2024
Q2 | $288K | Sell |
12,860
-7,691
| -37% | -$172K | ﹤0.01% | 2064 |
|
|
2024
Q1 | $565K | Sell |
20,551
-1,293
| -6% | -$35.6K | ﹤0.01% | 1961 |
|
|
2023
Q4 | $666K | Sell |
21,844
-2,121
| -9% | -$64.7K | ﹤0.01% | 1895 |
|
|
2023
Q3 | $758K | Buy |
23,965
+3,440
| +17% | +$109K | ﹤0.01% | 1878 |
|
|
2023
Q2 | $837K | Buy |
20,525
+721
| +4% | +$29.4K | ﹤0.01% | 1867 |
|
|
2023
Q1 | $738K | Sell |
19,804
-31
| -0.2% | -$1.16K | ﹤0.01% | 1903 |
|
|
2022
Q4 | $692K | Buy |
19,835
+1,253
| +7% | +$43.7K | ﹤0.01% | 1911 |
|
|
2022
Q3 | $1.04M | Buy |
18,582
+1,035
| +6% | +$57.9K | ﹤0.01% | 1834 |
|
|
2022
Q2 | $908K | Sell |
17,547
-8,123
| -32% | -$420K | ﹤0.01% | 1936 |
|
|
2022
Q1 | $1.87M | Sell |
25,670
-2,705
| -10% | -$197K | ﹤0.01% | 1871 |
|
|
2021
Q4 | $3.36M | Sell |
28,375
-93,053
| -77% | -$11M | ﹤0.01% | 1775 |
|
|
2021
Q3 | $16.3M | Buy |
121,428
+6,823
| +6% | +$915K | 0.01% | 1100 |
|
|
2021
Q2 | $18.6M | Buy |
114,605
+89,624
| +359% | +$14.5M | 0.01% | 1036 |
|
|
2021
Q1 | $2.01M | Buy |
24,981
+157
| +0.6% | +$12.6K | ﹤0.01% | 1851 |
|
|
2020
Q4 | $1.35M | Buy |
+24,824
| New | +$1.35M | ﹤0.01% | 1875 |
|
|
2020
Q3 | – | Sell |
-10,437
| Closed | -$219K | – | 2340 |
|
|
2020
Q2 | $219K | Buy |
+10,437
| New | +$219K | ﹤0.01% | 2169 |
|